vs

Side-by-side financial comparison of EMERSON RADIO CORP (MSN) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.

EMERSON RADIO CORP is the larger business by last-quarter revenue ($1.9M vs $996.0K, roughly 1.9× PAVmed Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -36.7%, a 6502.5% gap on every dollar of revenue. On growth, PAVmed Inc. posted the faster year-over-year revenue change (25.9% vs -52.8%).

Emerson Radio Corporation is one of the United States' largest volume consumer electronics distributors and has a recognized trademark in continuous use since 1912. The company designs, markets, and licenses many product lines worldwide, including products sold, and sometimes licensed, under the brand name G Clef, an homage to Emerson's logo.

PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.

MSN vs PAVM — Head-to-Head

Bigger by revenue
MSN
MSN
1.9× larger
MSN
$1.9M
$996.0K
PAVM
Growing faster (revenue YoY)
PAVM
PAVM
+78.7% gap
PAVM
25.9%
-52.8%
MSN
Higher net margin
PAVM
PAVM
6502.5% more per $
PAVM
6465.8%
-36.7%
MSN

Income Statement — Q3 FY2026 vs Q3 FY2024

Metric
MSN
MSN
PAVM
PAVM
Revenue
$1.9M
$996.0K
Net Profit
$-694.0K
$64.4M
Gross Margin
10.9%
-38.7%
Operating Margin
-43.7%
-1162.4%
Net Margin
-36.7%
6465.8%
Revenue YoY
-52.8%
25.9%
Net Profit YoY
-31.7%
464.4%
EPS (diluted)
$-0.03
$1.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSN
MSN
PAVM
PAVM
Q4 25
$1.9M
Q3 25
$1.2M
Q2 25
$1.7M
Q1 25
$1.8M
Q4 24
$4.0M
Q3 24
$2.7M
$996.0K
Q2 24
$2.2M
$979.0K
Q1 24
$2.2M
$1.0M
Net Profit
MSN
MSN
PAVM
PAVM
Q4 25
$-694.0K
Q3 25
$-1.0M
Q2 25
$-1.1M
Q1 25
$-2.4M
Q4 24
$-527.0K
Q3 24
$-881.0K
$64.4M
Q2 24
$-962.0K
$-10.8M
Q1 24
$-883.0K
$-15.2M
Gross Margin
MSN
MSN
PAVM
PAVM
Q4 25
10.9%
Q3 25
-0.1%
Q2 25
0.7%
Q1 25
-3.0%
Q4 24
12.3%
Q3 24
9.9%
-38.7%
Q2 24
8.8%
-70.2%
Q1 24
15.9%
-72.7%
Operating Margin
MSN
MSN
PAVM
PAVM
Q4 25
-43.7%
Q3 25
-98.4%
Q2 25
-78.1%
Q1 25
-137.8%
Q4 24
-18.3%
Q3 24
-40.8%
-1162.4%
Q2 24
-55.6%
-1397.8%
Q1 24
-52.2%
-1389.7%
Net Margin
MSN
MSN
PAVM
PAVM
Q4 25
-36.7%
Q3 25
-85.8%
Q2 25
-68.1%
Q1 25
-127.9%
Q4 24
-13.2%
Q3 24
-32.2%
6465.8%
Q2 24
-43.8%
-1105.9%
Q1 24
-40.1%
-1506.1%
EPS (diluted)
MSN
MSN
PAVM
PAVM
Q4 25
$-0.03
Q3 25
$-0.05
Q2 25
$-0.05
Q1 25
$-0.10
Q4 24
$-0.03
Q3 24
$-0.04
$1.44
Q2 24
$-0.05
$-1.19
Q1 24
$-0.04
$-2.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSN
MSN
PAVM
PAVM
Cash + ST InvestmentsLiquidity on hand
$13.3M
$765.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$18.6M
$-4.9M
Total Assets
$20.1M
$30.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSN
MSN
PAVM
PAVM
Q4 25
$13.3M
Q3 25
$13.5M
Q2 25
$15.5M
Q1 25
$16.1M
Q4 24
$16.4M
Q3 24
$16.7M
$765.0K
Q2 24
$18.9M
$25.5M
Q1 24
$19.9M
$25.5M
Stockholders' Equity
MSN
MSN
PAVM
PAVM
Q4 25
$18.6M
Q3 25
$19.3M
Q2 25
$20.4M
Q1 25
$21.5M
Q4 24
$23.9M
Q3 24
$24.4M
$-4.9M
Q2 24
$25.3M
$-73.9M
Q1 24
$26.2M
$-68.8M
Total Assets
MSN
MSN
PAVM
PAVM
Q4 25
$20.1M
Q3 25
$20.7M
Q2 25
$23.3M
Q1 25
$23.5M
Q4 24
$26.4M
Q3 24
$26.6M
$30.6M
Q2 24
$28.5M
$39.4M
Q1 24
$29.1M
$37.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSN
MSN
PAVM
PAVM
Operating Cash FlowLast quarter
$-228.0K
$-8.9M
Free Cash FlowOCF − Capex
$-8.9M
FCF MarginFCF / Revenue
-892.5%
Capex IntensityCapex / Revenue
0.0%
0.6%
Cash ConversionOCF / Net Profit
-0.14×
TTM Free Cash FlowTrailing 4 quarters
$-45.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSN
MSN
PAVM
PAVM
Q4 25
$-228.0K
Q3 25
$-2.0M
Q2 25
$-514.0K
Q1 25
$-391.0K
Q4 24
$-293.0K
Q3 24
$-2.1M
$-8.9M
Q2 24
$-840.0K
$-11.7M
Q1 24
$-2.2M
$-13.1M
Free Cash Flow
MSN
MSN
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-301.0K
Q3 24
$-2.1M
$-8.9M
Q2 24
$-1.0M
$-11.7M
Q1 24
$-2.3M
$-13.2M
FCF Margin
MSN
MSN
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-7.5%
Q3 24
-77.8%
-892.5%
Q2 24
-46.4%
-1190.9%
Q1 24
-102.3%
-1302.1%
Capex Intensity
MSN
MSN
PAVM
PAVM
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
0.3%
0.6%
Q2 24
8.2%
0.3%
Q1 24
0.5%
4.2%
Cash Conversion
MSN
MSN
PAVM
PAVM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.14×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSN
MSN

Products$1.8M95%
Other$87.0K5%

PAVM
PAVM

Segment breakdown not available.

Related Comparisons